Liang Lin
Direttore/Membro del Consiglio presso Shenzhen Ionova Life Sciences Co., Ltd.
Profilo
Liang Lin is a professional with experience in various directorial positions.
Currently, he holds directorial positions at Dizal Pharma, Shenzhen Ionova Life Sciences Co., Ltd., and Acerand Therapeutics Ltd.
In the past, he has worked as a Director at Shenyang Xingqi Pharmaceutical Co., Ltd., Sansure Biotech, Inc., and Dizal (Jiangsu) Pharmaceutical Co., Ltd.
He has also served as a Non-Executive Director at CanSino Biologics, Inc. Additionally, he worked as a Manager-Business Development at GlaxoSmithKline (China) Investment Co., Ltd.
Mr. Lin holds an MBA from China Europe International Business School and undergraduate and graduate degrees from China Pharmaceutical University.
Posizioni attive di Liang Lin
| Società | Posizione | Inizio |
|---|---|---|
Shenzhen Ionova Life Sciences Co., Ltd.
 Shenzhen Ionova Life Sciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Ionova Life Sciences Co., Ltd. develops anti-tumor drugs. The private company is based in Shenzhen, China. | Direttore/Membro del Consiglio | - |
Acerand Therapeutics Ltd.
 Acerand Therapeutics Ltd. BiotechnologyHealth Technology Acerand Therapeutics Ltd. discovers and develops small molecule drugs for cancer treatment. The private company is based in Pudong, China. | Direttore/Membro del Consiglio | - |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Liang Lin
| Società | Posizione | Fine |
|---|---|---|
| CANSINO BIOLOGICS INC. | Direttore/Membro del Consiglio | 21/02/2024 |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | 06/09/2023 |
| SANSURE BIOTECH INC. | Direttore/Membro del Consiglio | 01/07/2022 |
| SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. | Direttore/Membro del Consiglio | 06/01/2021 |
GlaxoSmithKline (China) Investment Co., Ltd.
 GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (China) Investment Co., Ltd. researches, develops, and wholesales pharmaceuticals, vaccines, and consumer healthcare products. The company is based in Beijing, China. | Corporate Officer/Principal | 01/04/2010 |
Formazione di Liang Lin
| China Pharmaceutical University | Graduate Degree |
| China Europe International Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| CANSINO BIOLOGICS INC. | Health Technology |
| SANSURE BIOTECH INC. | Health Technology |
| SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. | Health Technology |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Commercial Services |
| Aziende private | 4 |
|---|---|
GlaxoSmithKline (China) Investment Co., Ltd.
GlaxoSmithKline (China) Investment Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline (China) Investment Co., Ltd. researches, develops, and wholesales pharmaceuticals, vaccines, and consumer healthcare products. The company is based in Beijing, China. | Health Technology |
Shenzhen Ionova Life Sciences Co., Ltd.
Shenzhen Ionova Life Sciences Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Ionova Life Sciences Co., Ltd. develops anti-tumor drugs. The private company is based in Shenzhen, China. | Health Technology |
Acerand Therapeutics Ltd.
Acerand Therapeutics Ltd. BiotechnologyHealth Technology Acerand Therapeutics Ltd. discovers and develops small molecule drugs for cancer treatment. The private company is based in Pudong, China. | Health Technology |
Dizal Pharma
Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Health Technology |
- Borsa valori
- Insiders
- Liang Lin
